CHICAGO -- An investigational proximal hypoglossal nerve stimulation device helped control obstructive sleep apnea (OSA), the OSPREY randomized trial showed. The Apnea-Hypopnea Index (AHI) response ...
A nerve-stimulation treatment for obstructive sleep apnea that originally was approved only for people with body mass indexes (BMIs) in the healthy range recently was extended to patients with BMIs up ...
If you’ve struggled with this treatment, nerve stimulation may offer a path forward. Previously, people with moderate to severe OSA “who were intolerant to CPAP machines had no other treatment options ...
A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an implanted stimulation therapy targeting specific sectors of nerves in the ...
Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the senior and corresponding author and Brian Skotko, MD, MPP, the director of the Down ...
The first hypoglossal nerve-stimulation device (brand name Inspire) was approved by the U.S. Food and Drug Administration (FDA) in 2014 for use in patients with BMIs less than 25 whose moderate to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with active stimulation had improvements in ...
A new method of stimulating the hypoglossal nerve can improve outcomes for patients with obstructive sleep apnea, according to a recent randomized control trial published in Annals of Internal ...
The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results